AUS
NZ
UK
CA
USA
IND
Healthcare
CSL Decides Against CEO Salary Raise While Board Members Take A Healthy Pay Rise
September 14, 2018 07:48 AM AEST| By Team Kalkine MediaCSL Limited (ASX: CSL) has decided not to give any raise to CEO Paul Perreault in his base pay this year. The remuneration committee has decided to stay put on Perreault?s fixed pay or short-term reward target for the second consecutive year. As deci...
Lifespot Health pressed the pause button on ASX
September 14, 2018 07:21 AM AEST| By Team Kalkine MediaLifespot Health Limited?s stock went into trading halt today. In an announcement to ASX, health care group Lifespot Health requested ASX to grant trading halt pending an announcement in relation to an acquisition. Subsequently, the securities of Life...
Primary Health Care Announces the Release of Determination by the Fair Work Commission
September 14, 2018 05:34 AM AEST| By Team Kalkine MediaLeading healthcare company in Australia, Primary Health Care Limited (ASX: PRY) announced that Fair Work Commission has released a decision and drafted workplace determination which is relating to support employees that includes Pathology collectors,...
Creso seeks shareholders’ approval for Columbian Kunna acquisition
September 14, 2018 04:59 AM AEST| By Team Kalkine MediaCannabis company Creso Pharma Limited ( ASX: CPH ) announced the notice of general meeting which is to be held on 16th October 2018, at West Perth, Australia. It is to receive shareholder?s approval for completing the acquisition transaction with Kun...
Telix Pharmaceuticals completes the acquisition of France-based biotechnology company Atlab Pharma
September 14, 2018 03:39 AM AEST| By Team Kalkine MediaTelix Pharmaceuticals (ASX: TLX) completes the acquisition of French biotechnology company Atlab Pharma for USD$10 million in shares. Biopharmaceutical company Telix address unmet medical need in prostate, rental and brain cancer by developing a port...
2 exciting small-cap healthcare shares on our watchlist - NAN and PGC
September 13, 2018 09:11 AM AEST| By Team Kalkine MediaTrophon 2 to push growth: Nanosonics Limited (ASX: NAN) failed to post good numbers in FY18 with the decline of almost 79% in the net income after tax at $5.75 Mn compared to $26.15 Mn in the previous comparable period. However, the major reason behi...
One Healthcare stock on the watchlist - Nanosonic Limited
September 13, 2018 07:00 AM AEST| By Team Kalkine MediaNanosonics? stock continues to slide lower as the company?s revenue has squeezed in the financial year ended 30 June 2018. However, the FY18 results were in line with investor?s expectation as the company has heavily invested in its next generation T...
Imagion Biosystems moves closer to first-in-human clinical study
September 11, 2018 07:37 AM AEST| By Team Kalkine MediaHealthcare company Imagion Biosystems has announced the success in achieving a key milestone of optimizing nanoparticle formulation in a drive to first-in-human testing. In the announcement to ASX on 10 September 2018, the company has reported succe...
G Medical Innovations Enters Final Phase of Commercial Approval in China
September 06, 2018 07:28 AM AEST| By Team Kalkine MediaG Medical Innovations (ASX: GMV) updated that regulatory audits for its facility in China are scheduled to be conducted towards the end of this month and the outcome would be released in early October. The audit would bring the company a step closer...
Macquarie to sell its 95 million shares in Oceania Healthcare
September 05, 2018 03:59 PM AEST| By Team Kalkine MediaMacquarie Group (ASX: MQG) has gone on selling down some of its stakes in New Zealand based aged care service provider, Oceania Healthcare. As per the Oceania Healthcare?s disclosure to New Zealand Exchange, Macquarie Group has been found selling do...
Federal funding cuts wiped out Regis’ earnings
September 05, 2018 03:44 PM AEST| By Team Kalkine MediaFunding cuts by Federal government took away Regis Healthcare?s (ASX: REG) earnings as the ASX listed aged care services provider reported lower EBITDA of $117.1 million for the financial year ended 30 June 2018. This represents a 5% decline in grou...
Starpharma’s DEP irinotecan showed significant anti-cancer efficacy with complete tumour regression
September 05, 2018 07:59 AM AEST| By Team Kalkine MediaStarpharma Holdings Limited?s (ASX: SPL) share price surged 3.387% to $1.282 after announcing that its proprietary DEP irinotecan development candidate showed complete tumour regression and 100% survival in a human pancreatic cancer model. This is co...
Pro Medicus Limited (ASX: PME)- Pro Medicus’ shares are on fire today
September 03, 2018 01:07 PM AEST| By Team Kalkine MediaPro Medicus? (ASX: PME) stock jumped 6.869% to $10.890 on 3 September 2018 after the healthcare technology company recently announced strong full years results for the period ended 30 June 2018. Profit after tax has gone up by 36.7% to $12.74 millio...
Starpharma Holdings Limited (ASX: SPL)- Starpharma’s shares runs on getting first patent published
August 31, 2018 03:00 PM AEST| By Team Kalkine MediaStarpharma?s stock price jumped 13.04% to $1.30 on 31 August 2018 after the AstraZeneca?s first patent application on Starpharma?s DEP dendrimer with AstraZeneca?s Bcl2/xL inhibitors got published by the World Intellectual Property organization. The...
Zenitas’ stock rockets as consortium agrees to acquire 100% of Zenitas
August 31, 2018 06:08 AM AEST| By Team Kalkine MediaZenitas Healthcare (ASX: ZNT ) shares sky-rocketed 22.51% to $1.415 (31 August 2018; 1:50 PM AEST) on the release of scheme implementation deed announcing 100% of the Zenitas acquisition by Adamantem Capital and Liverpool Partners consortium for $1.4...
Mesoblast Limited (ASX: MSB)- Mesoblast’s stock climbed on FY18 revenue growth
August 30, 2018 04:01 PM AEST| By Team Kalkine MediaMesoblast Limited (ASX: MSB) today announced full year financial results for the 12 months ended 30 June 2018.? Revenue increased by US$14.8 million to US$17.3 million benefitting from commercialization revenue on sales of TEMCELL and payments receiv...
Ramsay Health Care Limited (ASX: RHC)- Ramsay Health Care arrowed down on ASX as net profit declined 20.6%
August 30, 2018 07:41 AM AEST| By Team Kalkine MediaRamsay Health Care (ASX: RHC) reported 7.0% rise in core earnings per share to 279.8 cents and 6.8% rise in core net profit to $579.3 million for the year ended 30 June 2018. Group?s revenue increased 5.4% to $9.2 billion including 5.5% growth in Aus...
Mesoblast Limited (ASX: MSB)- Mesoblast announces Chinese government approval to Tasly’s overseas investment
August 29, 2018 10:18 AM AEST| By Team Kalkine MediaMesoblast Limited (ASX: MSB) has today announced that Chinese pharmaceutical company Tasly Pharmaceutical Group has got China?s government approval of overseas direct investment to carry forward investment agreement as well as a development and colla...
BWX Limited confirms the expectation of lower than anticipated earnings
August 29, 2018 06:28 AM AEST| By Team Kalkine MediaBWX Limited (ASX: BWX) has finally released its results for the year ended 30 June 2018 which were earlier supposed to be announced on 15 August 2018. Earnings before interest tax, depreciation and amortization (EBITDA) downgraded on guidance range o...
Blackmores Limited (ASX: BKL) – Rocketing on 19% growth in profit
August 28, 2018 06:40 AM AEST| By Team Kalkine MediaBlackmores share price jumped up $16.24 after the company announced 19% hike in profit, thus delivering $70 million NPAT for the financial year ended 30 June 2018. Blackmores, (ASX: BKL) engaged in development, sales and marketing of health products...
Advertise your brand on Kalkine Media